Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Crinetics Pharmaceuticals, Inc. (CRNX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
25 Jan 2024
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
73,298
-3%
3,000
$37.26
$111,779.99
SELL
10 Jan 2024
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
76,298
-3%
3,000
$37.65
$112,950.01
SELL
3 Jan 2024
Pizzuti Dana
Chief Med and Dev Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
5,911
-70%
14,375
$35.00
$503,125.00
SELL
2 Jan 2024
Wilson Marc
CFO, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
96,055
-9%
10,000
$35.47
$354,700.00
SELL
26 Dec 2023
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
79,298
-3%
3,000
$35.89
$107,670.00
SELL
21 Dec 2023
Pizzuti Dana
Chief Med and Dev Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
5,911
-61%
9,583
$34.57
$331,284.30
SELL
2 Nov 2023
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
135,522
-59%
200,000
$30.56
$6,111,440.00
SELL
1 Nov 2023
Wilson Marc
CFO, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
95,601
-9%
10,000
$28.75
$287,500.00
SELL
11 Jul 2023
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
630,805
-7%
50,000
$20.21
$1,010,316.75
SELL
20 Jun 2023
Wilson Marc
CFO, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
95,158
-24%
30,922
$19.97
$617,403.10
SELL
16 Jun 2023
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
680,805
-6%
50,000
$20.81
$1,040,500.00
BUY
8 Jun 2023
Vivaldi Coelho Rogerio
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
5,000
+100%
5,000
$22.06
$110,300.00
SELL
3 Apr 2023
Pizzuti Dana
Chief Development Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
4,500
-64%
8,212
$16.15
$132,623.80
SELL
1 Feb 2023
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
64,689
-4%
3,126
$19.59
$61,238.34
SELL
25 Jan 2023
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
67,815
-10%
8,336
$21.07
$175,639.52
SELL
17 Jan 2023
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
76,151
-3%
3,126
$18.00
$56,268.00
SELL
3 Jan 2023
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
79,277
-3%
3,126
$18.35
$57,362.10
SELL
15 Dec 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
82,403
-3%
3,126
$16.00
$50,016.00
SELL
1 Dec 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
84,968
-3%
3,126
$17.84
$55,767.84
SELL
15 Nov 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
88,094
-3%
3,126
$18.72
$58,518.72
SELL
1 Nov 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
91,220
-3%
3,126
$18.52
$57,893.52
SELL
17 Oct 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
94,346
-3%
3,126
$17.73
$55,423.98
SELL
3 Oct 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
97,472
-3%
3,126
$19.64
$61,394.64
SELL
26 Jul 2022
Knight Jeff E.
Chief Operating Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
4,950
-18%
1,152
$20.70
$23,846.86
SELL
13 Jul 2022
Fust Matthew K
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
12,536
-31%
5,700
$20.96
$119,454.91
SELL
2 May 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
107,598
-2%
3,247
$20.10
$65,251.72
SELL
18 Apr 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
110,845
-4%
5,664
$25.81
$146,187.84
BUY
18 Apr 2022
PERCEPTIVE ADVISORS LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
5,321,032
+3%
157,515
$22.22
$3,499,983.20
SELL
13 Apr 2022
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
844,774
-14%
138,643
$26.83
$3,719,625.50
SELL
5 Apr 2022
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
869,448
-2%
21,357
$25.34
$541,224.80
SELL
4 Apr 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
116,509
-7%
9,000
$23.97
$215,761.50
SELL
31 Mar 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
125,509
-6%
8,328
$21.43
$178,474.86
SELL
15 Mar 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
133,837
-2%
3,123
$18.94
$59,149.62
BUY
28 Feb 2022
Madan Ajay
Chief Development Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
176,995
+5%
9,000
$19.88
$178,920.00
SELL
28 Feb 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
136,960
-2%
3,123
$19.73
$61,616.79
SELL
15 Feb 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
123,583
-2%
3,123
$18.64
$58,212.72
SELL
7 Feb 2022
Madan Ajay
Chief Development Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
172,045
-7%
13,411
$17.83
$239,084.60
SELL
1 Feb 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
126,706
-2%
3,123
$18.79
$58,681.17
SELL
19 Jan 2022
Krasner Alan Seth
Chief Medical Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
8,311
-44%
6,700
$21.21
$142,080.20
SELL
18 Jan 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
128,875
-3%
4,168
$23.29
$97,072.73
SELL
3 Jan 2022
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
133,043
-5%
7,168
$28.02
$200,847.36
SELL
28 Dec 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
140,211
-2%
3,000
$27.95
$83,851.80
SELL
15 Dec 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
143,211
-3%
5,668
$24.14
$136,825.52
SELL
1 Dec 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
148,879
-3%
5,668
$27.38
$155,189.83
SELL
15 Nov 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
154,547
-4%
7,168
$27.01
$193,574.00
SELL
5 Nov 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
161,715
-9%
16,500
$28.06
$463,041.00
SELL
1 Nov 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
178,215
-3%
5,668
$24.79
$140,509.72
SELL
1 Nov 2021
Fust Matthew K
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
12,536
-41%
8,954
$25.50
$228,327.00
SELL
27 Oct 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
183,883
-1%
3,000
$24.00
$71,991.00
BUY
25 Oct 2021
PERCEPTIVE ADVISORS LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
5,163,517
+30%
1,200,000
$19.80
$23,760,000.00
SELL
21 Oct 2021
Betz Stephen F.
Chief Scientific Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
186,883
-0%
1,042
$21.10
$21,983.60
SELL
8 Sep 2021
Fust Matthew K
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
12,536
-32%
6,046
$25.50
$154,173.00
SELL
7 Sep 2021
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
90,000
-25%
30,000
$25.00
$750,000.00
SELL
26 Jul 2021
Fust Matthew K
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
12,536
-28%
5,000
$19.59
$97,950.00
SELL
19 Jul 2021
Fust Matthew K
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
12,536
-28%
5,000
$19.50
$97,500.00
SELL
12 Jul 2021
Fust Matthew K
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
12,536
-28%
5,000
$20.71
$103,549.99
BUY
8 Apr 2021
PERCEPTIVE ADVISORS LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
3,963,517
+8%
304,136
$16.44
$4,999,996.00
BUY
2 Dec 2020
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
4,000
+500%
5,000
$13.00
$65,000.00
SELL
15 Jul 2020
Struthers Richard Scott
President & CEO, Director, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
890,805
-3%
35,000
$14.88
$520,829.75
BUY
17 Apr 2020
PERCEPTIVE ADVISORS LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
3,659,381
+41%
1,071,428
$14.00
$14,999,992.00
SELL
15 Apr 2020
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,162,587
-13%
330,598
$15.45
$5,106,752.00
SELL
3 Apr 2020
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,453,072
-11%
306,115
$13.81
$4,226,833.00
SELL
9 Mar 2020
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,722,045
-0%
528
$19.50
$10,296.00
SELL
7 Feb 2020
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,722,392
-0%
13,460
$21.66
$291,587.00
SELL
4 Feb 2020
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,724,977
-0%
13,460
$22.80
$306,888.00
SELL
29 Jan 2020
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,727,561
-0%
26,920
$22.07
$594,164.00
SELL
16 Dec 2019
Fust Matthew K
Director
Crinetics Pharmaceuticals, Inc.
(CRNX)
12,536
-21%
3,500
$22.50
$78,750.00
SELL
21 Jun 2019
5AM Ventures IV, L.P.
Former 10% holder
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,267,797
-9%
250,000
$22.20
$5,550,000.00
SELL
20 Mar 2019
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,732,730
-13%
417,000
$22.25
$9,278,250.00
SELL
18 Mar 2019
5AM Ventures IV, L.P.
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,507,797
-5%
154,839
$24.25
$3,754,954.00
SELL
22 Jan 2019
5AM Ventures IV, L.P.
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
3,107,642
-7%
262,153
$21.88
$5,734,597.00
BUY
20 Jul 2018
5AM Ventures IV, L.P.
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
3,359,309
+3%
115,000
$17.00
$1,955,000.00
BUY
20 Jul 2018
PERCEPTIVE ADVISORS LLC
Director, 10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,280,305
+21%
400,000
$17.00
$6,800,000.00
BUY
20 Jul 2018
Vivo Capital VIII, LLC
10% Owner
Crinetics Pharmaceuticals, Inc.
(CRNX)
3,025,339
+13%
353,180
$18.62
$6,575,421.00
BUY
20 Jul 2018
Krasner Alan Seth
Chief Medical Officer, Officer
Crinetics Pharmaceuticals, Inc.
(CRNX)
2,000
+100%
2,000
$17.00
$34,000.00
Home